Sphingoid bases are taken up by escherichia coli and staphylococcus aureus and induce ultrastructural damage

Skin Pharmacology and Physiology

Volumn 26, Issue 1, 2012, Pages 36-44

  Fischer, C L ^a   Walters, K S ^b   Drake, D R ^a   Blanchette, D R ^a   Dawson, D V ^a   Brogden, K A ^a   Wertz, P W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Department of Radiology and Medicine   (United States)

Author keywords

Antimicrobial lipids; Electron microscopy; Escherichia coli; Sphingoid bases; Sphingolipids; Staphylococcus aureus; Ultrastructure

Indexed keywords

PHYTOSPHINGOSINE; SPHINGANINE; SPHINGOSINE;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; CELL DEATH; CELL INCLUSION; CONTROLLED STUDY; ESCHERICHIA COLI; FAT CONTENT; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; SPHINGOSINE; STAPHYLOCOCCUS AUREUS;

EID: 84868244431     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000343175     Document Type: Article

References (43)

1. Brogden NK, Mehalick L, Fischer CL, et al: The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol 2012; 25: 167-181.
2. Jungersted JM, Hellgren LI, Jemec GB, et al: Lipids and skin barrier function - a clinical perspective. Contact Derm 2008; 58: 255- 262. (Pubitemid 351537624)
3. Bu S, Yamanaka M, Pei H, et al: Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2- Ets1 pathway in human fibroblasts. FASEB J 2006; 20: 184-186. (Pubitemid 43100508)
4. Shi L, Bielawski J, Mu J, et al: Involvement of sphingoid bases in mediating reactive oxygen intermediate production and programmed cell death in Arabidopsis. Cell Res 2007; 17: 1030-1040. (Pubitemid 350261800)
5. Saba JD, Hla T: Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 2004; 94: 724-734. (Pubitemid 38451733)
6. Spiegel S, Milstien S: The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 2011; 11: 403-415.
7. Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4: 397-407. (Pubitemid 36565571)
8. Darges JW, Robinson SP, Adams LM: Inhibition of leukotriene B4 (LTB4) in human neutrophils by L -threo-dihydrosphingosine. Adv Exp Med Biol 1997; 400A:387-392.
9. Kim S, Hong I, Hwang JS, et al: Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol Med 2006; 12: 17-24. (Pubitemid 44128374)
10. Pavicic T, Wollenweber U, Farwick M, et al: Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci 2007; 29: 181-190. (Pubitemid 47024255)
11. Drake DR, Brogden KA, Dawson DV, et al: Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 2008; 49: 4-11.
12. Bibel DJ, Aly R, Shinefield HR: Antimicrobial activity of sphingosines. J Invest Dermatol 1992; 98: 269-273.
13. Bibel DJ, Aly R, Shah S, et al: Sphingosines: antimicrobial barriers of the skin. Acta Derm Venereol 1993; 73: 407-411. (Pubitemid 23351334)
14. Klee SK, Farwick M, Lersch P: The effect of sphingolipids as a new therapeutic option for acne treatment. Basic Clin Derm 2007; 40: 155-166.
15. Bibel DJ, Aly R, Shinefield HR: Antimicrobial activity of sphingosines. J Invest Dermatol 1992; 98: 269-273.
16. Bibel DJ, Aly R, Shinefield HR: Inhibition of microbial adherence by sphinganine. Can J Microbiol 1992; 38: 983-985.
17. Bibel DJ, Aly R, Shah S, et al: Sphingosines: antimicrobial barriers of the skin. Acta Derm Venereol 1993; 73: 407-411. (Pubitemid 23351334)
18. Fischer CL, Drake D, Dawson DV, et al: Antibacterial activity of sphingoid bases and fatty acids against gram-positive bacteria and gram-negative bacteria. Antimicrob Agents Chemother 2012; 56: 1157-1161.
19. Klein E, Smith DL, Laxminarayan R: Hospitalizations and deaths caused by methicillinresistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13: 1840-1846.
20. Petkovsek Z, Elersic K, Gubina M, et al: Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol 2009; 47: 1811-1817.
21. Dryden MS: Complicated skin and soft tissue infection. J Antimicrob Chemother 2010; 65(suppl 3):iii35-44.
22. Wertz PW, Swartzendruber DC, Madison KC, et al: Composition and morphology of epidermal cyst lipids. J Invest Dermatol 1987; 89: 419-425. (Pubitemid 17158512)
23. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
24. Wertz PW, Downing DT: Free sphingosines in porcine epidermis. Biochim Biophys Acta 1989; 1002: 213-217. (Pubitemid 19090946)
25. Weerheim A, Ponec M: Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 2001; 293: 191-199. (Pubitemid 32391425)
26. Henk WG, Todd WJ, Enright FM, et al: The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli . Scanning Microsc 1995; 9: 501- 507.
27. Bayer ME, Carlemalm E, Kellenberger E: Capsule of Escherichia coli K29: ultrastructural preservation and immunoelectron microscopy. J Bacteriol 1985; 162: 985-991. (Pubitemid 15008142)
28. Bayer ME, Thurow H: Polysaccharide capsule of Escherichia coli : microscope study of its size, structure, and sites of synthesis. J Bacteriol. 1977; 130: 911-936. (Pubitemid 8108483)
29. Harder J, Bartels J, Christophers E, et al: Isolation and characterization of human betadefensin- 3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-5713.
30. Shimoda M, Ohki K, Shimamoto Y, et al: Morphology of defensin-treated Staphylococcus aureus . Infect Immun 1995; 63: 2886- 2891.
31. Brogden KA, De Lucca AJ, Bland J, et al: Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica . Proc Natl Acad Sci USA 1996; 93: 412-416. (Pubitemid 26038168)
32. Kalfa VC, Jia HP, Kunkle RA, et al: Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother 2001; 45: 3256-3261. (Pubitemid 32988867)
33. Bibel DJ, Aly R, Shinefield HR: Topical sphingolipids in antisepsis and antifungal therapy. Clin Exp Dermatol 1995; 20: 395- 400. (Pubitemid 26008814)
34. Payne CD, Ray TL, Downing DT: Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. J Invest Dermatol 1996; 106: 549-552. (Pubitemid 26117589)
35. Bergsson G, Arnfinnsson J, Steingrimsson O, et al: Killing of gram-positive cocci by fatty acids and monoglycerides. APMIS 2001; 109: 670-678. (Pubitemid 33020633)
36. Bergsson G, Arnfinnsson J, Steingrimsson O, et al: In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 2001; 45: 3209-3212. (Pubitemid 32988853)
37. Brogden KA: Cytopathology of pathogenic prokaryotes; in Cheville N (ed): Ultrastructural Pathology: The Cellular Basis of Disease. Ames, Blackwell, 2009, pp 425-524.
38. Alvarez HM, Steinbuchel A: Triacylglycerols in prokaryotic microorganisms. Appl Microbiol Biotechnol 2002; 60: 367-376. (Pubitemid 35435804)
39. Kalscheuer R, Stoveken T, Malkus U, et al: Analysis of storage lipid accumulation in Alcanivorax borkumensis : evidence for alternative triacylglycerol biosynthesis routes in bacteria. J Bacteriol 2007; 189: 918-928. (Pubitemid 46183867)
40. Hannun YA, Loomis CR, Merrill AH,Jr, et al: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 1986; 261: 12604-12609. (Pubitemid 17213985)
41. Takigawa H, Nakagawa H, Kuzukawa M, et al: Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus . Dermatology 2005; 211: 240-248. (Pubitemid 41415864)
42. Arikawa J, Ishibashi M, Kawashima M, et al: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus . J Invest Dermatol 2002; 119: 433-439. (Pubitemid 35001954)
43. Georgel P, Crozat K, Lauth X, et al: A Tolllike receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun 2005; 73: 4512-4521. (Pubitemid 41105605)